Zim Laboratories Limited — Others, 27-06-2025: Shareholders meeting

ZIM Laboratories Limited has announced the conclusion of its 41st Annual General Meeting where all eight resolutions were approved by shareholders with over 51% voting turnout. Key approvals included adoption of the financial results for the quarter and half-year, reappointment of Mr. Zulfiquar Kamal as director, appointment of Deloitte Haskins & Sells LLP as statutory auditors, ratification of remuneration for cost auditors, appointment of BNP & Associates as secretarial auditors, reappointment of Dr. Kamlesh Shende as independent director, appointment of Mr. Ashok Bhatia as independent director, and approval of remuneration to independent directors. Voting was predominantly in favor, reflecting strong shareholder support.